Explore by therapy
Start from a drug to confirm required biomarkers, indications, and eligible companion diagnostics.
Showing 92 TherapiesView in Know Your Companions™ →
AKEEGA (niraparib + abiraterone acetate)
Johnson & Johnson
Metastatic Castrate Resistant Prostate Cancer (mCRPC), Prostate Cancer
Click to view therapy contexts and tests.Open →
ALECENSA (alectinib)
Genentech
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ALHEMO (concizumab)
Novo Nordisk
Hemophilia A patients with or without factor VIII inhibitors and Hemophilia B patients with or without IX inhibitors
Click to view therapy contexts and tests.Open →
ALUNBRIG (brigatinib)
Takeda
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
AYVAKIT (avapritinib)
Blueprint Medicines
Gastrointestinal Stromal Tumors (GIST)
Click to view therapy contexts and tests.Open →
BALVERSA (erdafitinib)
Johnson & Johnson
Urothelial Cancer
Click to view therapy contexts and tests.Open →
BEQVEZ (fidanacogene elaparvovec)
Pfizer
Moderate to severe Hemophilia B patients
Click to view therapy contexts and tests.Open →
BRAFTOVI + ERBITUX
Pfizer / Eli Lilly
Colorectal Cancer (CRC), Metastatic Colorectal Cancer (mCRC)
Click to view therapy contexts and tests.Open →
BRAFTOVI + MEKTOVI
Pfizer
Melanoma, Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
COTELLIC + ZELBORAF
Genentech
Melanoma
Click to view therapy contexts and tests.Open →
ELAHERE (mirvetuximab soravtansine-gynx)
AbbVie
Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Click to view therapy contexts and tests.Open →
ELEVIDYS (delandistrogene moxeparvovec-rokl)
Sarepta Therapeutics
Duchenne Muscular Dystrophy (DMD)
Click to view therapy contexts and tests.Open →
EMRELIS (telisotuzumab vedotin-tllv)
AbbVie
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ENHERTU (fam-trastuzumab deruxtecan-nxki)
Daiichi Sankyo / AstraZeneca
Breast Cancer, Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ENHERTU + PERJETA
Daiichi Sankyo / AstraZeneca / Genentech
Breast Cancer
Click to view therapy contexts and tests.Open →
ENSACOVE (ensartinib)
Xcovery Holdings, Inc.
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ERBITUX (cetuximab)
Eli Lilly
Colorectal Cancer (CRC)
Click to view therapy contexts and tests.Open →
EXJADE (deferasirox)
Novartis
Non-Transfusion-Dependent Thalassemia
Click to view therapy contexts and tests.Open →
GAVRETO (pralsetinib)
Rigel Pharmaceuticals
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
GILOTRIF (afatinib)
Boehringer Ingelheim
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
GLEEVEC (imatinib mesylate)
Novartis
Aggressive Systemic Mastocytosis, Myelodysplastic Syndromes (MDS)
Click to view therapy contexts and tests.Open →
HERCEPTIN (trastuzumab)
Genentech
Breast Cancer, Gastric and Gastroesophageal Cancer
Click to view therapy contexts and tests.Open →
HERNEXEOS (zongertinib)
Boehringer Ingelheim
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
HYRNUO (sevabertinib)
Bayer
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
IDHIFA (enasidenib)
Bristol Myers Squibb / Servier Pharmaceuticals
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
IMCIVREE (setmelanotide acetate)
Rhythm Pharmaceuticals
Obesity
Click to view therapy contexts and tests.Open →
IMFINZI (durvalumab)
AstraZeneca
Endometrial Carcinoma (EC)
Click to view therapy contexts and tests.Open →
INLURIYO (imlunestrant)
Eli Lilly
Breast Cancer
Click to view therapy contexts and tests.Open →
IRESSA (gefitinib)
AstraZeneca
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ITOVEBI + IBRANCE + FASLODEX
Genentech / AstraZeneca
Breast Cancer
Click to view therapy contexts and tests.Open →
JEMPERLI (dostarlimag-gxly)
GSK
Endometrial Carcinoma (EC), Solid Tumors
Click to view therapy contexts and tests.Open →
KADCYLA (ado-trastuzumab emtansine)
Genentech
Breast Cancer
Click to view therapy contexts and tests.Open →
KEYTRUDA (pembrolizumab)
Merck
Cervical Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Esophageal or Gastroesophageal Junction (GEJ) Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Solid Tumors, Triple-Negative Breast Cancer (TNBC)
Click to view therapy contexts and tests.Open →
KEYTRUDA + LENVIMA
Merck / Eisai Co., Ltd.
Endometrial Carcinoma (EC)
Click to view therapy contexts and tests.Open →
KIMMTRAK (tebentafusp-tebn)
Bristol Myers Squibb
Uveal Melanoma
Click to view therapy contexts and tests.Open →
KRAZATI (adagrasib)
Bristol Myers Squibb
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
KRAZATI + ERBITUX
Bristol Myers Squibb / Eli Lilly
Colorectal Cancer (CRC)
Click to view therapy contexts and tests.Open →
LAZCLUZE + RYBREVANT
Johnson & Johnson
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
LIBTAYO (cemiplimab-rwlc)
Regeneron
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
LORBRENA (lorlatinib)
Pfizer
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
LUMAKRAS (sotorasib)
Amgen
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
LUMAKRAS + VECTIBIX
Amgen
Colorectal Cancer (CRC)
Click to view therapy contexts and tests.Open →
LYNPARZA (olaparib)
AstraZeneca / Merck
Breast Cancer, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Ovarian Cancer, Pancreatic Cancer
Click to view therapy contexts and tests.Open →
LYNPARZA + ZYTIGA
AstraZeneca / Merck
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Click to view therapy contexts and tests.Open →
MEKINIST (trametinib)
Novartis
Melanoma
Click to view therapy contexts and tests.Open →
OJEMDA (tovorafenib)
Day One Biopharmaceuticals, Inc.
Low-Grade Glioma
Click to view therapy contexts and tests.Open →
OPDIVO (nivolumab)
Bristol Myers Squibb
Colorectal Cancer (CRC), Esophageal squamous cell carcinoma (ESCC), and gastric, gastroesophageal junction (GEJ) and esophageal adenocarcinoma
Click to view therapy contexts and tests.Open →
OPDIVO + YERVOY
Bristol Myers Squibb
Colorectal Cancer (CRC), Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ORSERDU (elacestrant)
Stemline Therapeutics
Breast Cancer
Click to view therapy contexts and tests.Open →
PEMAZYRE (pemigatinib)
Incyte
Cholangiocarcinoma
Click to view therapy contexts and tests.Open →
PERJETA (pertuzumab)
Genentech
Breast Cancer
Click to view therapy contexts and tests.Open →
PIQRAY (alpelisib)
Novartis
Breast Cancer
Click to view therapy contexts and tests.Open →
QFITLIA (fitusiran)
Sanofi
Hemophilia A patients with or without factor VIII inhibitors and Hemophilia B patients with or without IX inhibitors
Click to view therapy contexts and tests.Open →
RETEVMO (selpercatinib)
Eli Lilly
Medullary Thyroid Cancer (MTC), Non-Small Cell Lung Cancer (NSCLC), Solid Tumors, Thyroid Cancer (TC)
Click to view therapy contexts and tests.Open →
REVUFORJ (revumenib)
Syndax Pharmaceuticals, Inc.
Acute Leukemia
Click to view therapy contexts and tests.Open →
REZLIDHIA (olutasidenib)
Rigel Pharmaceuticals
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
ROCTAVIAN (valoctocogene roxaparvovec-rvox)
BioMarin
Hemophilia A Patients
Click to view therapy contexts and tests.Open →
ROZLYTREK (entrectinib)
Genentech
Non-Small Cell Lung Cancer (NSCLC), Solid Tumors
Click to view therapy contexts and tests.Open →
RUBRACA (rucaparib)
Pharma&
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Click to view therapy contexts and tests.Open →
RYBREVANT (amivantamb)
Johnson & Johnson
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
RYDAPT (midostaurin)
Novartis
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
TABRECTA (capmatinib)
Novartis
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TAFINLAR (dabrafenib)
Novartis
Melanoma
Click to view therapy contexts and tests.Open →
TAFINLAR + MEKINIST
Novartis
Anaplastic Thyroid Cancer (ATC), Melanoma, Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TAGRISSO (osimertinib)
AstraZeneca
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TALZENNA (talazoparib)
Pfizer
Breast Cancer
Click to view therapy contexts and tests.Open →
TALZENNA + XTANDI
Pfizer / Astellas Pharma
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Click to view therapy contexts and tests.Open →
TARCEVA (erlotinib)
Genentech
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TASIGNA (nilotinib)
Novartis
Chronic Myeloid Leukemia (CML)
Click to view therapy contexts and tests.Open →
TAZVERIK (tazemetostat)
Ipsen
Follicular Lymphoma Tumor
Click to view therapy contexts and tests.Open →
TECELRA (afamitresgene autoleucel)
Adaptimmune
Synovial sarcoma
Click to view therapy contexts and tests.Open →
TECENTRIQ (atezolizumab)
Genentech
Muscle Invasive Bladder Cancer (MIBC), Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TECENTRIQ + COTELLIC + ZELBORAF
Genentech
Melanoma
Click to view therapy contexts and tests.Open →
TEPMETKO (tepotinib)
Merck KGaA
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
TIBSOVO (ivosidenib)
Servier Pharmaceuticals
Acute Myeloid Leukemia (AML), Cholangiocarcinoma, Myelodysplastic Syndromes (MDS)
Click to view therapy contexts and tests.Open →
TRUQAP (capivasertib)
AstraZeneca
Metastatic hormone-sensitive prostate cancer (mHSPC)
Click to view therapy contexts and tests.Open →
TRUQAP + FASLODEX
AstraZeneca
Breast Cancer
Click to view therapy contexts and tests.Open →
VANFLYTA (quizartinib)
Daiichi Sankyo
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
VECTIBIX (panitumumab)
Amgen
Colorectal Cancer (CRC)
Click to view therapy contexts and tests.Open →
VENCLEXTA (venetoclax)
Genentech / AbbVie
B-cell Chronic Lymphocytic Leukemia (CLL)
Click to view therapy contexts and tests.Open →
VEPANNU (vepdegestrant)
Rigel Pharmaceuticals
Breast Cancer
Click to view therapy contexts and tests.Open →
VITRAKVI (larotrectinib)
Bayer
Solid Tumors
Click to view therapy contexts and tests.Open →
VIZIMPRO (dacomitinib)
Pfizer
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
VORANIGO (vorasidenib)
Servier Pharmaceuticals
Astrocytoma and Oligodendroglioma
Click to view therapy contexts and tests.Open →
VYLOY (zolbetuximab)
Astellas Pharma
Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Click to view therapy contexts and tests.Open →
XALKORI (crizotinib)
Pfizer
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
XOSPATA (gilterinib)
Astellas Pharma
Acute Myeloid Leukemia (AML)
Click to view therapy contexts and tests.Open →
ZEGFROVY (sunvozertinib)
Dizal Pharmaceutical
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →
ZEJULA (niraparib)
GSK
Ovarian Cancer
Click to view therapy contexts and tests.Open →
ZELBORAF (vemurafenib)
Genentech
Melanoma
Click to view therapy contexts and tests.Open →
ZIIHERA (zanidatamab-hrii)
Jazz Pharmaceuticals
Biliary Tract Cancer, Gastroesophageal Adenocarcinoma (gastric, gastroesophageal junction, and esophageal adenocarcinoma)
Click to view therapy contexts and tests.Open →
ZYKADIA (ceritinib)
Novartis
Non-Small Cell Lung Cancer (NSCLC)
Click to view therapy contexts and tests.Open →